Levbid Extended Release
All of the following adverse reactions have been reported with hyoscyamine sulfate. Adverse reactions may include dryness of the mouth; urinary hesitancy and retention; blurred vision; tachycardia; palpitations; mydriasis; increased ocular tension; loss of taste; headache; nervousness; drowsiness; weakness; fatigue; dizziness; insomnia; nausea; vomiting; impotence; constipation; bloated feeling; abdominal pain; diarrhea; allergic reactions or drug idiosyncrasies; urticaria and other dermal manifestations; ataxia; speech disturbance; some degree of mental confusion and/or excitement (especially in elderly persons); short-term memory loss; hallucinations; and decreased sweating.
Read the Levbid Extended Release (hysocyamine sulfate extended release tablets) Side Effects Center for a complete guide to possible side effects
Additive adverse effects resulting from cholinergic blockade may occur when Levbid® (hysocyamine sulfate extended release tablets) is administered concomitantly with other antimuscarinics, amantadine, haloperidol, phenothiazines, monoamine oxidase (MAO) inhibitors, tricyclic antidepressants or some antihistamines.
Antacids may interfere with the absorption of Levbid® (hysocyamine sulfate extended release tablets) .
Read the Levbid Extended Release Drug Interactions Center for a complete guide to possible interactions
Last reviewed on RxList: 3/13/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Levbid Extended Release Information
Report Problems to the Food and Drug Administration
Get the latest treatment options.